2021 WHO 筛查和治疗宫颈癌前病变以预防宫颈癌的指南,第二版:使用 mRNA 检测检测人乳头瘤病毒 ( HPV):网络附件

2021-12-21 世界卫生组织 WHO官网

这份世卫组织和 HRP 指南旨在帮助各国在宫颈癌筛查和治疗方面取得更快、更公平的进展。本文件包括有关宫颈筛查的一个重要附加选项的指南。使用mRNA(信使RNA)HPV检测。这为各国在考虑在其筛查计划中

中文标题:

2021 WHO 筛查和治疗宫颈癌前病变以预防宫颈癌的指南,第二版:使用 mRNA 检测检测人乳头瘤病毒 ( HPV):网络附件

英文标题:

WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (‎HPV): web annex

发布机构:

世界卫生组织

发布日期:

2021-12-21

简要介绍:

这份世卫组织和 HRP 指南旨在帮助各国在宫颈癌筛查和治疗方面取得更快、更公平的进展。本文件包括有关宫颈筛查的一个重要附加选项的指南。使用mRNA(信使RNA)HPV检测。这为各国在考虑在其筛查计划中使用哪种类型的 HPV 核酸扩增检测 (NAAT) 提供了额外的选择。  

相关资料下载:
[AttachmentFileName(sort=1, fileName=WHO 筛查和治疗宫颈癌前病变以预防宫颈癌的指南,第二版:使用 mRNA 检测检测人乳头瘤病毒 ( HPV):网络附件.pdf)] GetToolGuiderByIdResponse(projectId=1, id=31e341c00230a9e5, title=2021 WHO 筛查和治疗宫颈癌前病变以预防宫颈癌的指南,第二版:使用 mRNA 检测检测人乳头瘤病毒 ( HPV):网络附件, enTitle=WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (‎HPV): web annex, guiderFrom=WHO官网, authorId=0, author=, summary=这份世卫组织和 HRP 指南旨在帮助各国在宫颈癌筛查和治疗方面取得更快、更公平的进展。本文件包括有关宫颈筛查的一个重要附加选项的指南。使用mRNA(信使RNA)HPV检测。这为各国在考虑在其筛查计划中, cover=https://img.medsci.cn/20211228/1640659244529_5579292.jpg, journalId=0, articlesId=null, associationId=138, associationName=世界卫生组织, associationIntro=null, copyright=0, guiderPublishedTime=Tue Dec 21 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>这份世卫组织和 HRP 指南旨在帮助各国在宫颈癌筛查和治疗方面取得更快、更公平的进展。本文件包括有关宫颈筛查的一个重要附加选项的指南。使用mRNA(信使RNA)HPV检测。这为各国在考虑在其筛查计划中使用哪种类型的 HPV 核酸扩增检测 (NAAT) 提供了额外的选择。&nbsp;&nbsp;</p>, tagList=[TagDto(tagId=839, tagName=HPV), TagDto(tagId=1402, tagName=宫颈癌), TagDto(tagId=16960, tagName=人类乳头瘤病毒(HPV))], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21053, categoryName=梅斯医学-宫颈癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=839, guiderKeyword=HPV, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2732, appHits=153, showAppHits=0, pcHits=715, showPcHits=2579, likes=1, shares=32, comments=3, approvalStatus=1, publishedTime=Tue Dec 28 10:39:10 CST 2021, publishedTimeString=2021-12-21, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Dec 28 10:47:37 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Wed Jan 03 16:47:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=WHO 筛查和治疗宫颈癌前病变以预防宫颈癌的指南,第二版:使用 mRNA 检测检测人乳头瘤病毒 ( HPV):网络附件.pdf)])
WHO 筛查和治疗宫颈癌前病变以预防宫颈癌的指南,第二版:使用 mRNA 检测检测人乳头瘤病毒 ( HPV):网络附件.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1179621, encodeId=729711e9621cc, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:23:33 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179620, encodeId=6abc11e9620fa, content=已经下载了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:23:29 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179282, encodeId=72f711e9282c0, content=已经下载了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940a6415403, createdName=ms9000000767522532, createdTime=Fri Dec 31 14:09:44 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-01-01 一己怀

    好东西

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1179621, encodeId=729711e9621cc, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:23:33 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179620, encodeId=6abc11e9620fa, content=已经下载了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:23:29 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179282, encodeId=72f711e9282c0, content=已经下载了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940a6415403, createdName=ms9000000767522532, createdTime=Fri Dec 31 14:09:44 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-01-01 一己怀

    已经下载了,谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1179621, encodeId=729711e9621cc, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:23:33 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179620, encodeId=6abc11e9620fa, content=已经下载了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:23:29 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179282, encodeId=72f711e9282c0, content=已经下载了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940a6415403, createdName=ms9000000767522532, createdTime=Fri Dec 31 14:09:44 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2021-12-31 ms9000000767522532

    已经下载了,谢谢

    0

拓展阅读

2015 SGO/ASCCP 高危HPV检测用于宫颈癌初筛的中期指南

美国妇科肿瘤学会(SGO,Society of Gynecologic Oncology) · 2015-01-08

2016 BC指南:女性生殖系统肿瘤:HPV相关肿瘤(宫颈、阴道和外阴)(修订版)

不列颠哥伦比亚省临床实践指南中心(BC,Clinical Practice Guidelines and Protocols in British Columbia) · 2016-07-15

2017 CAP指南:头颈部恶性肿瘤患者人类乳头瘤病毒检测

美国病理学家协会(CAP,College of American Pathologists) · 2017-12-18

2017年WHO HPV疫苗立场文件的解读

暂未更新 · 2018-05-15